Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

290 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Low molecular weight heparins: are they different?
Fareed J, Hoppensteadt D, Jeske W, Clarizio R, Walenga JM. Fareed J, et al. Among authors: walenga jm. Can J Cardiol. 1998 Aug;14 Suppl E:28E-34E. Can J Cardiol. 1998. PMID: 9779031 Review.
Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia.
Lewis BE, Wallis DE, Berkowitz SD, Matthai WH, Fareed J, Walenga JM, Bartholomew J, Sham R, Lerner RG, Zeigler ZR, Rustagi PK, Jang IK, Rifkin SD, Moran J, Hursting MJ, Kelton JG; ARG-911 Study Investigators. Lewis BE, et al. Among authors: walenga jm. Circulation. 2001 Apr 10;103(14):1838-43. doi: 10.1161/01.cir.103.14.1838. Circulation. 2001. PMID: 11294800 Clinical Trial.
Low molecular weight heparins. An objective overview.
Hoppensteadt D, Walenga JM, Fareed J. Hoppensteadt D, et al. Among authors: walenga jm. Drugs Aging. 1992 Sep-Oct;2(5):406-22. doi: 10.2165/00002512-199202050-00005. Drugs Aging. 1992. PMID: 1327312 Review.
290 results